<DOC>
	<DOCNO>NCT01509261</DOCNO>
	<brief_summary>This study compare Ilaprazole 20mg lansoprazole 30mg heal erosive esophagitis resolution heartburn .</brief_summary>
	<brief_title>Efficacy Study Ilaprazole Treat Erosive Esophgitis</brief_title>
	<detailed_description />
	<mesh_term>Esophagitis</mesh_term>
	<mesh_term>Lansoprazole</mesh_term>
	<mesh_term>Dexlansoprazole</mesh_term>
	<criteria>Subject must endoscopically confirm erosive esophagitis define Los Angeles ( LA ) Classification Grading System ( AD ) within 14 day prior baseline . Episodes heartburn regurgitation experience last 7 day prior baseline . Coexisting disease affect esophagus ( eg , eosinophilic esophagitis , esophageal varix , scleroderma , viral fungal infection , esophageal stricture ) , history radiation therapy cryotherapy esophagus , caustic physiochemical trauma sclerotherapy esophagus . Presence Schatzki 's ring ( ring mucosal tissue near low esophageal sphincter ) Barrett 's esophagus exclusionary . Current history ZollingerEllison syndrome acid hypersecretory condition , current gastric duodenal ulcer . Known hypersensitivity PPI ( include lansoprazole , omeprazole , rabeprazole , pantoprazole esomeprazole ) , component ilaprazole , Gelusil . Cancer ( except basal cell carcinoma skin ) within 5 year prior screen .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>Erosive Esophagitis</keyword>
	<keyword>Ilaprazole</keyword>
	<keyword>GERD</keyword>
</DOC>